Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telithromycin vs. Azithromycin in Acute Maxillary Sinusitis
NCT00245440Phase 4Terminated
- Sponsor
- CPL Associates
- Start
- Dec 2005
- Countries
- 1
01
Overview
Phase 4, randomised trial of telithromycin in maxillary sinusitis (2 arms), sponsored by CPL Associates. Primary endpoint: Bacterial resistance or selection at 42 days. Started Dec 2005; status: terminated.
02
Drugs
telithromycin
03
Conditions
maxillary sinusitis
Beyond the preview
Go deeper on NCT00245440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00245440.